Latest Market News

Scales Corporation has declared a final FY2025 dividend of 12.5 cents per share, lifting total dividends for the year to 25 cents, representing 59% of underlying net profit. The company also introduced a Dividend Reinvestment Plan offering shares at a 2% discount.

Promisia Healthcare reported a 58% jump in underlying EBITDAF to $6.6 million for FY26, driven by improved occupancy and operational upgrades. The company introduced a dividend policy tied to operating free cash flow, signalling confidence in sustained cash generation.

Templeton Emerging Markets Investment Trust (TEMIT) posted a robust 41.3% net asset value total return for FY2026, outpacing its benchmark and narrowing its share price discount, while maintaining dividends and expanding share buybacks.

The ACCC has moved Peter Warren Automotive’s proposed acquisition of 30 Wakeling Automotive dealerships to a Phase 2 review, citing risks of reduced competition in Sydney’s Macarthur region.

The ACCC has moved Peter Warren Automotive’s acquisition of Wakeling Automotive’s 30 dealership sites into a Phase 2 review amid concerns it could dominate Sydney’s Macarthur region new car market, controlling 25 of 33 dealerships locally.

Nova Minerals has secured New South Wales Supreme Court approval for its schemes of arrangement, paving the way for its US holding company to take control and triggering ASX delisting and NYSE admission.

Northern Star Resources acknowledges Elliott Investment Management's views and reiterates its focus on leadership succession, project milestones, and strategic corporate reviews.

ImpediMed has revamped its leadership with two new commercial roles and reported encouraging sales momentum for its SOZO device. The company is advancing clinical trials and expanding its presence in cancer survivorship, weight management, and heart health sectors.

Australian Finance Group (ASX:AFG) has kicked off a $15 million on-market share buyback, aiming to return capital to shareholders while maintaining strategic flexibility amid recent share price softness.

Vitrafy Life Sciences has teamed up with Vitalant Innovation Center to tackle the impending gap in red blood cell cryopreservation technology in the US, aiming to replace soon-to-be-discontinued legacy methods and potentially expand into other blood products.

The Takeovers Panel has declined to investigate Skin Elements Limited's allegations of undisclosed investor associations following a $2.5 million placement, after 62 Capital agreed to waive transfer restrictions on placement securities.

DroneShield has landed a $24.9 million contract with the US Department of War’s Joint Interagency Task Force 401 to supply mobile and fixed counter-drone solutions, reinforcing its foothold in the US defence market.